Precipio, Inc. reported preliminary, unaudited results for the fourth quarter and full fiscal year 2025, showing total revenue of $24.0 million—an increase of 30 % from $18.5 million in 2024. Q4 revenue rose to $6.7 million, up 23 % from $5.4 million in Q4 2024, and the company’s overall revenue growth was driven by continued demand for its pathology services and proprietary diagnostic products.
Continue reading for full analysis...